A person is seen entering JPMorgan Chase & Co.'s headquarters in Manhattan, New York City. This image was captured by Reuters.
JPMorgan Chase has announced new leadership roles to strengthen its healthcare and technology investment banking divisions, according to an internal memo viewed by Reuters on Thursday.
Ben Carpenter and Jeremy Meilman have been appointed as global co-heads of the healthcare investment banking unit. Meanwhile, Chris Grose and Greg Mendelson have taken on the roles of global co-heads for technology investment banking. These changes come as JPMorgan seeks to expand its influence in these growing sectors.
Investment banking has been a strong area for JPMorgan and other major Wall Street firms, as companies increasingly seek to raise funds through debt or equity sales and pursue takeover deals. This surge in activity is driven by renewed confidence in the U.S. economy. JPMorgan reported better-than-expected earnings in the second quarter of this year, with dealmaking activities and strong capital markets contributing significantly to this success.
In July, the bank revealed that its investment banking revenue jumped 46% to $2.5 billion for the quarter ending in June, compared to the same period last year. This growth was fueled by a resurgence in dealmaking activity and a stable financial outlook for the U.S. economy.
Ben Carpenter, a veteran in the industry, returned to JPMorgan from Citigroup in 2021 to work in healthcare mergers and acquisitions (M&A). According to the memo, his co-head, Jeremy Meilman, has been with JPMorgan for almost 20 years. On the technology side, Chris Grose joined JPMorgan's technology and diversified industries team in 2005, while Greg Mendelson, who started with the firm in 2015, was most recently vice-chair of investment banking.
In the memo, Doug Petno and Filippo Gori, co-heads of JPMorgan's global banking division, emphasized that Carpenter, Meilman, Grose, and Mendelson would bring valuable networks, strategic insights, and market expertise to their new roles. The new leaders are expected to help guide the bank's growth in the healthcare and technology sectors.
Alongside these appointments, JPMorgan also named Mike Gaito the global chair of healthcare investment banking. Additionally, Pankaj Goel, Madhu Namburi, and Drago Rajkovic were named global chairs of technology investment banking. These leaders are set to drive strategic growth and offer a broader range of services to clients in the healthcare and technology industries.
With this leadership shuffle, JPMorgan is positioning itself to capitalize on the increasing opportunities in healthcare and technology, two sectors that are expected to see continued growth in the coming years.
